4//SEC Filing
JOHNSON BRENT 4
Accession 0000898432-20-000487
CIK 0001325618other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 7:16 PM ET
Size
19.2 KB
Accession
0000898432-20-000487
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
JOHNSON BRENT
Exec. VP, Sales & Marketing
Transactions
- Exercise/Conversion
Common Stock
2020-04-06$1.48/sh+4,000$5,920→ 6,940 total - Sale
Common Stock
2020-04-06$20.09/sh−4,000$80,360→ 2,940 total - Exercise/Conversion
Common Stock
2020-04-07$1.48/sh+4,000$5,920→ 6,940 total - Sale
Common Stock
2020-04-08$20.01/sh−4,000$80,040→ 2,940 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-04-08−4,000→ 118,474 totalExercise: $1.48Exp: 2023-12-31→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2020-04-08$1.48/sh+4,000$5,920→ 6,940 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-04-06−4,000→ 126,474 totalExercise: $1.48Exp: 2023-12-31→ Common Stock (4,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-04-07−4,000→ 122,474 totalExercise: $1.48Exp: 2023-12-31→ Common Stock (4,000 underlying) - Sale
Common Stock
2020-04-07$20.03/sh−4,000$80,120→ 2,940 total
Footnotes (5)
- [F1]The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $20.00 to $20.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $20.00 to $20.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $20.00 to $20.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This option, representing a right to purchase a total of 199,759 shares, was granted on December 31, 2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. 49,939 shares from this award were previously exercised in December 2015.
Documents
Issuer
IRADIMED CORP
CIK 0001325618
Entity typeother
Related Parties
1- filerCIK 0001254747
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 7:16 PM ET
- Size
- 19.2 KB